Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hamilton

Showing results (981-990 of 1,112) with videos related to

Pageof 112
Sort By:
The Journal of Urology|July 24, 2020
Microhematuria: AUA/SUFU GuidelineDaniel A Barocas, Stephen A Boorjian, Ronald D Alvarez, et al.
Open Forum Infectious Diseases|May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind TrialSelin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
The New England Journal of Medicine|July 10, 2014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitisLisa A Beck, Diamant Thaçi, Jennifer D Hamilton, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
The New England Journal of Medicine|May 22, 2018
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe AsthmaKlaus F Rabe, Parameswaran Nair, Guy Brusselle, et al.
Brain, Behavior, & Immunity - Health|August 21, 2023
Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 diseaseJuan P Zuniga-Hertz, Ramamurthy Chitteti, Joe Dispenza, et al.
BMC Infectious Diseases|February 21, 2014
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern TanzaniaElizabeth A Reddy, Boniface N Njau, Susan C Morpeth, et al.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
Pageof 112

Showing results (981-990 of 1,112) with videos related to

Sort By:
Pageof 112
The Journal of Urology|July 24, 2020
Microhematuria: AUA/SUFU GuidelineDaniel A Barocas, Stephen A Boorjian, Ronald D Alvarez, et al.
Open Forum Infectious Diseases|May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind TrialSelin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
The New England Journal of Medicine|July 10, 2014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitisLisa A Beck, Diamant Thaçi, Jennifer D Hamilton, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
The New England Journal of Medicine|May 22, 2018
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe AsthmaKlaus F Rabe, Parameswaran Nair, Guy Brusselle, et al.
Brain, Behavior, & Immunity - Health|August 21, 2023
Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 diseaseJuan P Zuniga-Hertz, Ramamurthy Chitteti, Joe Dispenza, et al.
BMC Infectious Diseases|February 21, 2014
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern TanzaniaElizabeth A Reddy, Boniface N Njau, Susan C Morpeth, et al.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
Pageof 112